NCT05135585View on ClinicalTrials.gov

Evaluation of the Post-vaccination Immune Response to COVID-19 in the New Caledonian Population

NACompletedINTERVENTIONAL
Enrollment

680

Participants

Timeline

Start Date

December 1, 2021

Primary Completion Date

September 17, 2022

Study Completion Date

September 17, 2022

Conditions
SARS-CoV-2 Acute Respiratory Disease
Interventions
OTHER

Blood sample collection

Blood sample collection at 1 month and 6 months after vaccination

OTHER

Questionnaires

data collection (health data, vaccination data, etc.)

Trial Locations (3)

Unknown

Centre Hospitalier Territorial de Nouvelle-Calédonie, Dumbéa Sur Mer

Centre hospitalier spécialisé de Nouvelle-Calédonie, Noumea

Vaccination centers, Province Sud

Sponsors

Lead Sponsor

Institut Pasteur
All Listed Sponsors
collaborator

Centre Hospitalier Spécialisé de Nouvelle-Calédonie

UNKNOWN

collaborator

Direction de l'Action Sanitaire et Sociale

OTHER_GOV

collaborator

Centre Hospitalier Territorial de Nouvelle-Calédonie

OTHER

collaborator

Agence sanitaire et sociale de la Nouvelle Calédonie

UNKNOWN

lead

Institut Pasteur

INDUSTRY

NCT05135585 - Evaluation of the Post-vaccination Immune Response to COVID-19 in the New Caledonian Population | Biotech Hunter | Biotech Hunter